thalidomide has been researched along with As If Personality in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psychiatric and personality disorders have been extensively documented in patients with systemic lupus erythematosus (SLE)." | 1.46 | High Prevalence of Personality Disorders in Skin-restricted Lupus Patients. ( Bonnefond, S; Collange, M; D'Incan, M; Jalenques, I; Labeille, B; Massoubre, C; Mulliez, A; Perrot, JL; Rondepierre, F; Schwan, R, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jalenques, I | 1 |
| Rondepierre, F | 1 |
| Massoubre, C | 1 |
| Bonnefond, S | 1 |
| Schwan, R | 1 |
| Labeille, B | 1 |
| Perrot, JL | 1 |
| Collange, M | 1 |
| Mulliez, A | 1 |
| D'Incan, M | 1 |
1 other study available for thalidomide and As If Personality
| Article | Year |
|---|---|
High Prevalence of Personality Disorders in Skin-restricted Lupus Patients.
Topics: Adult; Age of Onset; Case-Control Studies; Chi-Square Distribution; Dermatologic Agents; Female; Fra | 2017 |